Christopher Gorini, PhD, is a strategic R&D and clinical operations leader with over 20 years of experience in biotechnology, nonprofit, and government sectors. Currently serving as the Director of Pulmonary and Gastrointestinal Therapeutics at the Cystic Fibrosis Foundation, they lead initiatives to develop therapies for cystic fibrosis while fostering partnerships with various organizations. Previously, Christopher engaged in advanced research as a postdoctoral scholar at Stanford University and as a doctoral candidate at The George Washington University, where they earned their PhD in Molecular Medicine. Their expertise encompasses clinical operations, regulatory strategy, and cross-functional team leadership, all aimed at improving patient outcomes in infectious and rare diseases.
This person is not in any teams